Epsilon Healthcare Limited (9TH0) AI Stock Analysis

0 Followers

Epsilon Healthcare Limited

(Frankfurt:9TH0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue and Gross Margin ImprovementThe strong increase in revenue, alongside a materially higher gross margin, indicates improved scale and better economics in the current operating period. If maintained, this combination can support greater operating leverage, strengthen the business model, and provide a foundation for more durable profitability.

Negative Factors

Operating Profitability Remains NegativeRevenue and gross margin growth have not yet translated into positive operating earnings, with both EBIT and EBITDA still below zero. This leaves the recovery vulnerable to execution setbacks and means the company must achieve further scale or cost improvement before earnings can become reliably self-funding.

Epsilon Healthcare Limited (9TH0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 3.89M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): 80.0
Beta (1Y): -0.31
Revenue Growth: 117.80%
EPS Growth: ―
Country: Germany
Employees: 14
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Epsilon Healthcare Limited Business Overview & Revenue Model

Company Description

Epsilon Healthcare Limited operates as an Australian-based healthcare and pharmaceutical firm, with significant operations also extending into Canada. Established in 2016 and headquartered in Sydney, the company specializes in several areas: manufact...

Epsilon Healthcare Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:9TH0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AU:VLS	82Outperform	AUD 145.97M	13.20	19.91%	5.49%	12.19%	22.36%
AU:MVP	57Neutral	AUD 49.57M	76.78	1.13%	―	8.99%	450.00%
AU:LGP	52Neutral	AUD 57.96M	-15.00	-1.67%	―	15.21%	-141.82%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AU:PKP	39Underperform	AUD 18.75M	-5.07	4388.00%	―	-19.73%	50.34%
AU:IDT	34Underperform	AUD 14.06M	-5.31	-13.81%	―	5.93%	66.32%

* Healthcare Sector Average

Performance Comparison

DE:9TH0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:9TH0	Epsilon Healthcare Limited	0.01	-0.00	-16.67%
AU:VLS	Vita Life Sciences Limited	2.64	0.37	16.35%
AU:LGP	Little Green Pharma Ltd.	0.07	-0.06	-46.92%
AU:MVP	Medical Developments International Limited	0.43	-0.13	-23.21%
AU:PKP	Althea Group Holdings Ltd.	0.01	-0.01	-30.00%
AU:IDT	IDT Australia Limited	0.03	-0.02	-41.38%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Epsilon Healthcare Limited AI Stock Analysis